Solid lipid nanoparticles loaded transdermal patch of Rivastigmine Tartrate for Alzheimers disease by QbD (Quality by Design) approach
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Poster
- By: RAVI, G (JSS College of Pharmacy, Pharmaceutics, Mysuru, India)
- Co-author(s): G Ravi: Pharmaceutics, JSS College of Pharmacy, Mysuru, India
N. Vishal Gupta: Pharmaceutics, JSS College of Pharmacy, Mysuru, India
Rivastigmine transdermal patches for the treatment of Alzheimer’s disease have potential benefits compared to conventional capsule dosage form because of their sustained absorption, reduction of gastrointestinal problems and better tolerability.
The present investigation aims to increase bioavailability of Rivastigmine compared to.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.